Authors: Mormont, MC Waterhouse, J Bleuzen, P Giacchetti, S Jami, A Bogdan, A Lellouch, J Misset, JL Touitou, Y Levi, F

Citation: Mc. Mormont et al., Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status, CLIN CANC R, 6(8), 2000, pp. 3038-3045

Authors: Bensmaine, MA de Gramont, A Brienza, S Marty, M Levi, F Ducreux, M Francois, E Gamelin, E Bleiberg, H Bleuzen, P Simon, J Cvitkovic, E

Citation: Ma. Bensmaine et al., Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/- folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients, EUR J CANC, 36(18), 2000, pp. 2335-2343

Authors: Alexandre, J Bleuzen, P Bonneterre, J Sutherland, W Misset, JL Guastalla, JP Viens, P Faivre, S Chahine, A Spielman, M Bensmaine, A Marty, M Mahjoubi, M Cvitkovic, E

Citation: J. Alexandre et al., Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients, J CL ONCOL, 18(3), 2000, pp. 562-573

Authors: Goldwasser, F Buthaud, X Gross, M Bleuzen, P Cvitkovic, E Voinea, A Jasmin, C Romain, D Misset, JL

Citation: F. Goldwasser et al., Decreased topotecan platelet toxicity with successive topotecan treatment cycles in advanced ovarian cancer patients, ANTI-CANC D, 10(3), 1999, pp. 263-265